BioSpace News Archive

Business

Promore Pharma Release: Interim Report January - September 2017

Overall, the company’s main activities during the third quarter have been focused on continued planning of our clinical commitments.

November 21, 2017

·

6 min read

Drug Development

NewLink Genetics Announces the Presentation of Indoximod Data in Phase I Study for Children

The presentation entitled, “Radio-chemo-immunotherapy using the IDO-inhibitor indoximod for children with progressive brain tumors in the phase 1 setting” showed the combination of indoximod plus radiation was well-tolerated.

November 21, 2017

·

3 min read

Titan Medical Announces Upsizing of Previously Announced Marketed Offering of Units

Each Warrant is exercisable for one Common Share at a price of CDN $0.60, for a period of five years following the closing of the Offering.

November 21, 2017

·

4 min read

BioMidwest

Elekta Debuts Magnetic Resonance Radiation Therapy System to Enable Precision Oncology Therapy at RSNA Annual Meeting

Elekta’s MR-linac integrates an advanced linear accelerator with a diagnostic-standard MR imaging system and intelligent software into a single device.

November 21, 2017

·

3 min read

Drug Development

DelMar Presents Positive Interim Results From VAL-083 Study in MGMT-Unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

DelMar reported that 96% of patients enrolled were alive at the time of the analysis and 40% of patients enrolled were reported to have achieved stable disease as assessed by MRI following treatment with VAL-083 as a single agent.

November 21, 2017

·

8 min read

Valeant Announces Closing of Add-On Secured Notes and Credit Agreement Amendment

Valeant used the net proceeds from the offering of the Notes, along with cash on hand, to prepay a portion of its outstanding Series F Tranche B Term Loans due 2022 and to pay related fees and expenses.

November 21, 2017

·

1 min read

Business

Kewaunee Scientific Declares Quarterly Dividend

Kewaunee Scientific Corporation announced today its Board of Directors declared a quarterly cash dividend of seventeen cents per outstanding share, payable on December 18, 2017 to stockholders of record at the close of business on December 4, 2017.

November 21, 2017

·

1 min read

Intrexon Enters Into $100M Preferred Stock Equity

BioMidwest

Preceptis Medical Announces Series B Financing and Global Growth Strategy for China

This Series B financing will allow Preceptis to expand its commercial infrastructure and develop future pipeline technologies.

November 21, 2017

·

2 min read

Biotech Beach

Dartmouth and University of Southern California Studies Highlight ChromaCode HDPCR™ as Compelling Multiplexing Alternative

The two studies were presented during Association for Molecular Pathology 2017 Annual Meeting from November 16 - 18, 2017 in Salt Lake City, Utah.

November 21, 2017

·

2 min read

Policy

Starpharma: NDA Submission for VivaGel BV in the U.S.

VivaGel BV has been granted Fast Track status and Qualified Infectious Disease Product designation, which allows for rolling submission of the NDA and ensures priority regulatory review by the FDA.

November 21, 2017

·

2 min read